The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial. 30. Mai 2009 Hadji, P., Ziller, M., Kieback, D.G., Menschik, T., Kalder, M., Kuck, J., Hasenburg, A., 2009. Breast 18, 159–164. doi:10.1016/j.breast.2009.03.003 Abstract Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy. Hadji, P., Ziller, M., Kieback, D.G., Dornoff, W., Tessen, H.W., Menschik, T., Kuck, J., Melchert, F., Hasenburg, A., 2009. Ann Oncol 20, 1203–1209. doi:10.1093/annonc/mdn762… Weiterlesen Bendamustine in the treatment of chronic lymphocytic leukemia. Knauf, W., 2009 Expert Rev Anticancer Ther 9, 165–174. doi:10.1586/14737140.9.2.165 Abstract… Weiterlesen